ADDvise Group

ADDvise Group is a Sweden-based international life science and healthcare group that develops, manufactures, markets, and distributes products and services for healthcare and research facilities through a decentralized portfolio of operating subsidiaries. Its businesses are organized into two segments, Lab and Healthcare, spanning laboratory interiors and cleanrooms, lab instruments, medical devices, patient monitoring, diabetes supplies, pharmaceuticals distribution, and clinical trial support services. Rather than operating as a therapeutics developer, ADDvise grows primarily through acquisitions and local subsidiary operations. The company historically traded on Nasdaq First North Premier and, since 2026, has become part of the privately owned Swedish group Amplex AB. For a biotech analyst, ADDvise is best understood as a commercial-stage life science tools, medtech, and healthcare products/services consolidator rather than a drug pipeline company.